Avanos Medical Stock Forecast, Price & News

Avanos Medical (NYSE:AVNS) Frequently Asked Questions

Is Avanos Medical a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Avanos Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares.
View analyst ratings for Avanos Medical or view top-rated stocks.

How has Avanos Medical's stock price been impacted by Coronavirus (COVID-19)?

Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AVNS shares have increased by 4.1% and is now trading at $30.20.
View which stocks have been most impacted by COVID-19.

When is Avanos Medical's next earnings date?

Avanos Medical is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for Avanos Medical.

How were Avanos Medical's earnings last quarter?

Avanos Medical, Inc. (NYSE:AVNS) announced its quarterly earnings results on Tuesday, November, 2nd. The company reported $0.25 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.27 by $0.02. Avanos Medical had a positive trailing twelve-month return on equity of 3.67% and a negative net margin of 7.06%. During the same quarter last year, the company posted $0.21 EPS.
View Avanos Medical's earnings history.

What guidance has Avanos Medical issued on next quarter's earnings?

Avanos Medical issued an update on its FY 2021 earnings guidance on Tuesday, November, 9th. The company provided EPS guidance of $1.100-$1.200 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.140. The company issued revenue guidance of -.

What price target have analysts set for AVNS?

3 analysts have issued 12 month target prices for Avanos Medical's stock. Their forecasts range from $41.00 to $47.00. On average, they expect Avanos Medical's share price to reach $44.33 in the next year. This suggests a possible upside of 46.8% from the stock's current price.
View analysts' price targets for Avanos Medical or view top-rated stocks among Wall Street analysts.

Who are Avanos Medical's key executives?

Avanos Medical's management team includes the following people:

• Joseph F. Woody, Chief Executive Officer & Executive Director
• Michael C. Greiner, CFO, Chief Accounting Officer & Senior VP
• Lee Burnes, Senior VP-Global Research & Development
• Michelle Scharfenberg, Senior VP, Chief Ethics & Compliance Officer
• Rhonda D. Gibby, Chief Human Resources Officer & Senior VP

What is Joseph F. Woody's approval rating as Avanos Medical's CEO?

32 employees have rated Avanos Medical CEO Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among Avanos Medical's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Avanos Medical's key competitors?

Some companies that are related to Avanos Medical include MSA Safety (MSA), Establishment Labs (ESTA), Vicarious Surgical (RBOT), Inogen (INGN), Sientra (SIEN), Sanara MedTech (SMTI), Eargo (EAR), United Health Products (UEEC), Conformis (CFMS), Lakeland Industries (LAKE), Milestone Scientific (MLSS), Surgalign (SRGA), CollPlant Biotechnologies (CLGN), Invacare (IVC) and Alpha Pro Tech (APT).
View all of AVNS's competitors.

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Honeywell International (HON), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA).

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.14%), Paradice Investment Management LLC (6.42%), Dimensional Fund Advisors LP (4.51%), Macquarie Group Ltd. (3.58%), Goldman Sachs Group Inc. (2.98%) and Geode Capital Management LLC (1.68%). Company insiders that own Avanos Medical stock include Gary Blackford and Patrick J Oleary.
View institutional ownership trends for Avanos Medical.

Which major investors are selling Avanos Medical stock?

AVNS stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Dimensional Fund Advisors LP, Morgan Stanley, BlackRock Inc., Deutsche Bank AG, Goldman Sachs Group Inc., Maverick Capital Ltd., and Principal Financial Group Inc..
View insider buying and selling activity for Avanos Medical or view top insider-selling stocks.

Which major investors are buying Avanos Medical stock?

AVNS stock was acquired by a variety of institutional investors in the last quarter, including Paradice Investment Management LLC, Neuberger Berman Group LLC, Balyasny Asset Management LLC, Tributary Capital Management LLC, Two Sigma Advisers LP, Two Sigma Investments LP, Eagle Asset Management Inc., and Macquarie Group Ltd.. Company insiders that have bought Avanos Medical stock in the last two years include Gary Blackford, and Patrick J Oleary.
View insider buying and selling activity for Avanos Medical or or view top insider-buying stocks.

How do I buy shares of Avanos Medical?

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $30.20.

How much money does Avanos Medical make?

Avanos Medical has a market capitalization of $1.46 billion and generates $714.80 million in revenue each year. The company earns $-27.20 million in net income (profit) each year or ($1.10) on an earnings per share basis.

How many employees does Avanos Medical have?

Avanos Medical employs 5,300 workers across the globe.

What is Avanos Medical's official website?

The official website for Avanos Medical is avanos.com.

Where are Avanos Medical's headquarters?

Avanos Medical is headquartered at 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at (844) 428-2667 or via email at [email protected].